EVIDA Trademark

Trademark Overview


On Thursday, October 10, 2024, a trademark application was filed for EVIDA with the United States Patent and Trademark Office. The USPTO has given the EVIDA trademark a serial number of 98794121. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, March 27, 2025. This trademark is owned by PROMETHEUS LABORATORIES, INC.. The EVIDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for immune-mediated inflammatory diseases; Biologics for immune-mediated inflammatory diseases
evida

General Information


Serial Number98794121
Word MarkEVIDA
Filing DateThursday, October 10, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, March 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for immune-mediated inflammatory diseases; Biologics for immune-mediated inflammatory diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 10, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePROMETHEUS LABORATORIES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Thursday, October 10, 2024NEW APPLICATION ENTERED
Thursday, October 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 21, 2025ASSIGNED TO EXAMINER
Thursday, March 27, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 27, 2025NON-FINAL ACTION E-MAILED
Thursday, March 27, 2025NON-FINAL ACTION WRITTEN